Belova: A non-interventional study to collect data on the safety and efficacy of frontline bevacizumab treatment in Figo Stage IV Ovarian Cancer patients ≥ 70 (BELOVA) First published 21/06/2016 Last updated 02/07/2024 EU PAS number:EUPAS13849 Study Finalised